JP2007238598A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007238598A5 JP2007238598A5 JP2006307035A JP2006307035A JP2007238598A5 JP 2007238598 A5 JP2007238598 A5 JP 2007238598A5 JP 2006307035 A JP2006307035 A JP 2006307035A JP 2006307035 A JP2006307035 A JP 2006307035A JP 2007238598 A5 JP2007238598 A5 JP 2007238598A5
- Authority
- JP
- Japan
- Prior art keywords
- stroke
- patient
- composition
- composition according
- history
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002253 acid Substances 0.000 claims 3
- 125000004494 ethyl ester group Chemical group 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 2
- SSQPWTVBQMWLSZ-AAQCHOMXSA-N Ethyl eicosapentaenoic acid Chemical compound CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC SSQPWTVBQMWLSZ-AAQCHOMXSA-N 0.000 claims 1
- 210000002966 Serum Anatomy 0.000 claims 1
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006307035A JP5069448B2 (ja) | 2006-02-07 | 2006-11-13 | 脳卒中再発予防用組成物 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006029954 | 2006-02-07 | ||
JP2006029954 | 2006-02-07 | ||
JP2006307035A JP5069448B2 (ja) | 2006-02-07 | 2006-11-13 | 脳卒中再発予防用組成物 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006194043A Division JP4005104B2 (ja) | 2006-02-07 | 2006-07-14 | 脳卒中再発予防用組成物 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2007238598A JP2007238598A (ja) | 2007-09-20 |
JP2007238598A5 true JP2007238598A5 (de) | 2009-08-20 |
JP5069448B2 JP5069448B2 (ja) | 2012-11-07 |
Family
ID=38584473
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006307035A Active JP5069448B2 (ja) | 2006-02-07 | 2006-11-13 | 脳卒中再発予防用組成物 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5069448B2 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3578177A1 (de) | 2008-09-02 | 2019-12-11 | Amarin Pharmaceuticals Ireland Limited | Pharmazeutische zusammensetzungen mit eicosapentaensäure und nikotinsäure und verfahren zur verwendung davon |
NZ789295A (en) | 2009-04-29 | 2024-02-23 | Amarin Pharmaceuticals Ie Ltd | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
NZ627238A (en) | 2009-04-29 | 2016-02-26 | Amarin Pharmaceuticals Ie Ltd | Stable pharmaceutical composition comprising ethyl eicosapentaenoate |
CN114053258A (zh) | 2009-06-15 | 2022-02-18 | 阿马里纳药物爱尔兰有限公司 | 在相伴他汀类疗法的对象中降低甘油三酯、没有增加ldl-c水平的组合物和方法 |
NZ778131A (en) | 2010-11-29 | 2023-03-31 | Amarin Pharmaceuticals Ie Ltd | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
US11712429B2 (en) | 2010-11-29 | 2023-08-01 | Amarin Pharmaceuticals Ireland Limited | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
US11291643B2 (en) | 2011-11-07 | 2022-04-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
JP2015522029A (ja) | 2012-06-29 | 2015-08-03 | アマリン ファーマシューティカルス アイルランド リミテッド | スタチン療法中の患者における心血管系イベントの危険性を減少させる方法 |
US20150265566A1 (en) | 2012-11-06 | 2015-09-24 | Amarin Pharmaceuticals Ireland Limited | Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy |
US20140187633A1 (en) | 2012-12-31 | 2014-07-03 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis |
US9452151B2 (en) | 2013-02-06 | 2016-09-27 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing apolipoprotein C-III |
US9624492B2 (en) | 2013-02-13 | 2017-04-18 | Amarin Pharmaceuticals Ireland Limited | Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof |
US9283201B2 (en) | 2013-03-14 | 2016-03-15 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for treating or preventing obesity in a subject in need thereof |
US9585859B2 (en) | 2013-10-10 | 2017-03-07 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy |
US10172818B2 (en) | 2014-06-16 | 2019-01-08 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids |
CN112218630A (zh) | 2018-09-24 | 2021-01-12 | 阿马里纳药物爱尔兰有限公司 | 降低受试者的心血管事件的风险的方法 |
WO2022225896A1 (en) | 2021-04-21 | 2022-10-27 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing the risk of heart failure |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7022713B2 (en) * | 2004-02-19 | 2006-04-04 | Kowa Co., Ltd. | Hyperlipemia therapeutic agent |
-
2006
- 2006-11-13 JP JP2006307035A patent/JP5069448B2/ja active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2007238598A5 (de) | ||
ATE510537T1 (de) | Pharmazeutische zusammensetzungen von entacapon, levodopa und carbidopa mit verbesserter bioverfügbarkeit | |
JP2012517449A5 (de) | ||
JP2006504795A5 (de) | ||
RS54187B1 (en) | PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED RELEASE CONTAINING FUMARIC ACID ESTAR | |
WO2007012022A3 (en) | Unit dose form with ibuprofen-famotidine admixture | |
MA32692B1 (fr) | Procede de liberation d'une composition pharmaceutique a un patient qui en a besoin | |
JP2007523049A5 (de) | ||
IL191312A0 (en) | Oral pharmaceutical dosage form comprising as active ingredients a proton pump inhibitor together with acetyl salicyclic acid | |
UA110012C2 (uk) | Лікарські форми для перорального застосування, що містять ацетат лікарбазепіну | |
HRP20151202T1 (hr) | Oralna formulacija metadoksina | |
RS52867B (en) | GLATIRAMER ACETATOM AND RAZAGILIN COMBINED THERAPY FOR MULTIPLE SCLEROSIS | |
NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
HRP20170734T1 (hr) | Povećana biodostupnost lijeka u terapiji naltreksonom | |
JP2009516719A5 (de) | ||
RU2009142937A (ru) | Тапентадол для лечения в связи с остеоартрозом | |
MX2007006775A (es) | Composiciones estables de fenofibrato con esteres de acido graso. | |
MA28862B1 (fr) | Composition pharmaceutique sous forme de comprime a residence gastrique contenant un principe actif | |
JP2006342148A5 (de) | ||
WO2007121545A8 (en) | S-nitrosothiols containing compositions for the treatment of fatty liver diseases, obesity and other diseases associated with the metabolic syndrome and the use of such compositions | |
MX2009004579A (es) | Composicion farmaceutica que tiene actividad antisicotica, antidepresiva o antiepileptica, con efecto colateral reducido. | |
ATE460934T1 (de) | Pharmazeutische zubereitungen von ciprofloxacin | |
JP2012097034A5 (de) | ||
ATE534382T1 (de) | Pharmazeutische zusammensetzungen von mit zuckeralkoholen zusammen mikronisiertem entacapon | |
WO2009019307A3 (en) | Oral calcitonin compositions and applications thereof |